COLLABORATION AGREEMENTCollaboration Agreement • November 14th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • New York
This Collaboration Agreement (the “Agreement”) is effective as of November 7, 2023 (the “Effective Date”) by and between Schrödinger, Inc., a Delaware corporation having an address of 1540 Broadway, 21st Floor, New York, New York 10036 (“Schrödinger”), and Aconcagua Bio, Inc., a Delaware corporation having an address of 601 Gateway Blvd, Suite 900, South San Francisco, CA 94080 (“Aconcagua”). Each of Schrödinger and Aconcagua may hereinafter be referred to as a “party” to this Agreement or collectively as the “parties”.
